CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Training in Transplantation and Cellular Therapy in Latin America: A Cross-Sectional Study of the LABMT.
Training in Transplantation and Cellular Therapy in Latin America: A Cross-Sectional Study of the LABMT.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
造血细胞移植(HCT)是一项复杂且资源密集的医疗程序,已成为某些血液系统疾病的关键治疗手段。然而,拉丁美洲获得 HCT 的机会较高收入国家有限,原因之一是缺乏面向 HCT 专业人员的标准化培训项目。为弥补这一缺口,拉丁美洲骨髓移植组开展横断面研究,评估该地区 HCT 和细胞治疗培训项目的现状。
本研究旨在描述和分析拉丁美洲 HCT 培训项目的可及性、特征和挑战,重点识别障碍并提出改进方案。2022 年 12 月,研究向 14 个拉丁美洲国家的 127 家认可 HCT 中心发送横断面调查,收集机构特征、培训项目结构、费用和项目发展障碍等数据。采用描述性统计总结数据,并使用卡方检验和 Mann–Whitney 检验进行比较分析。在受访的 127 家中心中,50 家(39%)作出回应,大多数位于巴西(34%)和墨西哥(30%)。受访中心中,64%(n = 32)提供为期 6 个月或更长的正规培训项目。报告的主要障碍为资金不足(n = 21)、移植手术数量有限(n = 15)和合格教师短缺(n = 11)。提出的解决方案包括增加学员流动机会(n = 28)、提升项目质量(n = 27)和改善资金可及性(n = 15)。仅 6% 的项目提供 CAR-T 治疗实践机会,不到半数中心提供国际轮转。研究显示,拉丁美洲 HCT 培训项目存在显著差异,多数国家无法获得正规培训。巴西和墨西哥虽是区域枢纽,其他国家的培训机会却有限或缺乏。通过增加资金、加强国际合作和建立标准化课程来弥补这些差距,对于改善 HCT 培训和最终提升患者照护至关重要。
Hematopoietic cell transplantation (HCT) is a complex and resource-intensive procedure that has become a critical treatment for certain hematologic conditions.
However, in Latin America, access to HCT is limited compared to high-income countries, in part due to a lack of standardized training programs for HCT professionals. To address this gap, the Latin-American Bone Marrow Transplantation Group conducted a cross-sectional study to assess the current state of training programs in HCT and cellular therapy across the region.
This study aimed to describe and analyze the availability, characteristics, and challenges of HCT training programs in Latin America, with a focus on identifying barriers and proposing solutions for improvement. A cross-sectional survey was sent to 127 recognized HCT centers across 14 Latin-American countries in December 2022. The survey collected data on institutional characteristics, training program structure, costs, and barriers to program development. Descriptive statistics were used to summarize the data, and comparative analyses were performed using Chi-square and Mann-Whitney tests.
Of the 127 centers surveyed, 50 (39%) responded, with the majority located in Brazil (34%) and Mexico (30%). Among the respondents, 64% (n = 32) offered formal training programs lasting 6 months or longer. The most significant barriers reported were lack of funding (n = 21), limited number of transplant procedures (n = 15), and a shortage of qualified professors (n = 11).
Proposed solutions included increasing student mobility opportunities (n = 28), enhancing program quality (n = 27), and improving access to funding (n = 15). Only 6% of programs offered exposure to CAR-T therapy, and fewer than half of the centers provided international rotations.
This study highlights significant disparities in HCT training programs across Latin America, with most countries lacking access to formalized training. While Brazil and Mexico serve as regional hubs, other nations have limited or no training opportunities. Addressing these gaps through increased funding, international collaborations, and standardized curricula is essential to improving HCT training and ultimately patient care in the region.
MEMBER ACCOUNT
登录成功会直接打开下一页。